|
CLIP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.808600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.408600E-01 |
| Normal-vs-Stage2 |
1.936430E-01 |
| Normal-vs-Stage3 |
2.957800E-02 |
| Normal-vs-Stage4 |
2.688400E-01 |
| Stage1-vs-Stage2 |
4.610100E-02 |
| Stage1-vs-Stage3 |
3.271800E-02 |
| Stage1-vs-Stage4 |
5.120600E-01 |
| Stage2-vs-Stage3 |
5.256000E-03 |
| Stage2-vs-Stage4 |
4.492200E-02 |
| Stage3-vs-Stage4 |
4.002600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.666200E-02 |
| Normal-vs-AfricanAmerican |
7.326600E-01 |
| Normal-vs-Asian |
5.148800E-01 |
| Caucasian-vs-AfricanAmerican |
5.191400E-01 |
| Caucasian-vs-Asian |
5.395200E-01 |
| AfricanAmerican-vs-Asian |
8.487600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.849970E-01 |
| Normal-vs-Female |
5.641000E-01 |
| Male-vs-Female |
2.478200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.765200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.977800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.532200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.339760E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.606800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.036200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.232200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.785800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.087000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.132000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.289400E-01 |
| Classical-VS-Follicular |
2.255200E-03 |
| Classical-VS-Other |
2.453600E-01 |
| Classical-VS-Normal |
2.790600E-01 |
| Tall-VS-Follicular |
9.192200E-04 |
| Tall-VS-Other |
4.079800E-01 |
| Tall-VS-Normal |
6.829900E-02 |
| Follicular-VS-Other |
2.898900E-03 |
| Follicular-VS-Normal |
6.009600E-02 |
| Other-VS-Normal |
6.893900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.034200E-01 |
| Normal-vs-N1 |
8.381700E-02 |
| N0-vs-N1 |
2.399600E-01 |
|
|
